Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
10.69
+0.61 (6.05%)
Mar 31, 2026, 4:00 PM EDT - Market closed

Elicio Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
18.5617.6212.896.1688.76
Cash & Short-Term Investments
18.5617.6212.896.1688.76
Cash Growth
5.36%36.64%109.45%-93.06%156.47%
Other Receivables
----0.81
Total Trade Receivables
----0.81
Other Current Assets
0.753.083.454.561.69
Total Current Assets
19.3120.6916.3510.7291.25
Net Property, Plant & Equipment
5.086.197.288.54.44
Long-Term Investments
----0.72
Other Long-Term Assets
1.471.33.523.450.11
Total Assets
25.8628.1827.1522.6696.51
Accounts Payable
0.671.044.372.814.71
Accrued Expenses
6.438.423.761.943.22
Current Portion of Leases
1.010.90.910.690.89
Unearned Revenue
-1.170.691.442.3
Other Current Liabilities
2.622.830.04-0.17
Total Current Liabilities
8.1111.529.766.8711.3
Long-Term Debt
9.4120.03---
Long-Term Leases
4.095.116.016.793.48
Other Long-Term Liabilities
---0.090.24
Total Long-Term Liabilities
13.525.146.016.883.71
Total Liabilities
24.2339.4915.7713.7515.01
Common Stock
0.180.110.100.3
Treasury Stock
-0.15-0.15-0.15--
Additional Paid-in Capital
235.41183153.834.86296.45
Accumulated Other Comprehensive Income
-0.13-0.18-0.2--0.1
Retained Earnings
-233.67-194.1-142.2-107.01-215.14
Total Common Shareholders' Equity
1.64-11.3111.37-102.1581.51
Minority Interest
---111.06-
Shareholders' Equity
1.64-11.3111.378.9281.51
Total Liabilities & Equity
25.8628.1827.1522.6696.51
Total Debt
14.5126.046.927.484.37
Net Cash (Debt)
4.05-8.425.98-1.3384.39
Net Cash Per Share
0.27-0.691.18-0.9057.16
Book Value
1.64-11.3111.37-102.1581.51
Book Value Per Share
0.11-0.932.25-69.1955.21
Tangible Book Value
1.64-11.3111.37-102.1581.51
Tangible Book Value Per Share
0.11-0.932.25-69.1955.21
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q